A recent study on murine as well as patients with non-small cell lung cancer reveals that Tregs secret IL-10 and IL-35 to promote exhaustion of CD8+ TILs to limit effective anti-tumor immunity, resulting in poor prognosis [134]. The gene discussed is CD8A; the disease is neoplasm.